Antisense Oligonucleotide-Based Therapy of Viral Infections

Nucleic acid-based therapeutics have demonstrated their efficacy in the treatment of various diseases and vaccine development. Antisense oligonucleotide (ASO) technology exploits a single-strand short oligonucleotide to either cause target RNA degradation or sterically block the binding of cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarn, Woan-Yuh, Cheng, Yun, Ko, Shih-Han, Huang, Li-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707165/
https://www.ncbi.nlm.nih.gov/pubmed/34959297
http://dx.doi.org/10.3390/pharmaceutics13122015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707165/
https://www.ncbi.nlm.nih.gov/pubmed/34959297
http://dx.doi.org/10.3390/pharmaceutics13122015

Ejemplares similares